Art

J-GLOBAL ID：201402203038184202   Reference number：14A0115365

「新しい免疫抑制剤」抗CD25モノクローナル抗体daclizumab(ゼナパックス),basiliximab(シムレクト)

Author (1)： KENMOCHI TAKASHI (藤田保健衛生大 医 臓器移植科)
Material： 移植  (日本移植学会雑誌)
Volume： 48  Issue： 6  Page： 325-332  Publication year： Dec. 10, 2013 
JST Material Number： Z0653A  ISSN： 0578-7947  Document type： Article
Article type： 文献レビュー  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *immunosuppressant ,...
Semi thesaurus term： *zenapax ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0115365&from=J-GLOBAL&jstjournalNo=Z0653A") }}

JST classification (4)： Clinical application of immunotherapeutic agents and blood preparations  (GW22020O) ,  Surgical treatment for urogenital diseases  (GM05030G) ,  Transplantation immunity  (ED03020E) ,  Surgical treatment for digestive system diseases  (GH05030R)

Reference (41)：

• 1) Starzl TE, Marchioro TL, Faris TD, et al. Avenues of future research in homotransplantation of the liver with particular reference to hepatic supportive procedures, antilymphocyte serum, and tissue typing. Am J Surg 1966; 112: 391-400.
• 2) Jeejeebhoy HF, Singla O. Mode of recovery from the effects of heterologous anti-lymphocyte serum. I. Recovery of the immune response. Immunology 1972; 22: 789-799.
• 3) Woodruff MF. Antilymphocyte serum: summary and further observations. Transplantation 1967; 5: 1127-1133.
• 4) Humphrey LJ, Kauffman HM Jr, Dunn E. Heterologous antilymphocyte globulin: studies in vitro. Science 1967; 157: 441.
• 5) Lance EM, Dresser DW. Antigenicity in mice of antilymphocyte gamma-globulin. Nature 1967; 29; 215: 488-490.

Terms in the title (6)： 免疫抑制剤 ,  CD25 ,  モノクローナル抗体 ,  Daclizumab ,  ゼナパックス ,  シムレクト